SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : January Effect Investing 1999

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dale Baker who wrote (5)12/31/1998 6:53:00 AM
From: Q.  Read Replies (1) of 38
 
Dale, ERGO is indeed interesting. I read the filings and the news. Just as you said, it is selling for a fraction of cash. They are debt free, too.

The news they got is the worst they could imagine. There's little reason for the co. to exist now, after their only drug was not approved. Yet they do have that cash, which is at least 3 years of burn.

Usually I only invest in good companies, and never in penny stocks, but in this case the cash takes a lot of the worry out of the situation, and it seems like a reasonable play on the January effect. The RS is about as low as possible going into January, the stock price and market cap too, yet there's no way they can go out of business. So I bought a few shares for under a dollar. If it goes up only 1/4, it will quite a good return for the January effect.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext